Keywords: 1m, merck, co, research, grant, nccn, usa-based
$1M Merck & Co research grant for NCCN
Article | 08 December 2008
The USA-based National Comprehensive Cancer Network recently received a $1.0-million research grant from Merck & Co to fund clinical trials focusing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
